Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001214659-25-001409
Filing Date
2025-01-28
Accepted
2025-01-28 06:00:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 y127250424b3.htm 424B3 3801877
2 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
3 GRAPHIC pipeline_chart.jpg GRAPHIC 125185
  Complete submission text file 0001214659-25-001409.txt   3994398
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284350 | Film No.: 25560779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)